Effect of 10-Valent Pneumococcal Vaccine on Pneumonia among Children, Brazil
Pneumonia is most problematic for children in developing countries. In 2010, Brazil introduced a 10-valent pneumococcal conjugate vaccine (PCV10) to its National Immunization Program. To assess the vaccine’s effectiveness for preventing pneumonia, we analyzed rates of hospitalization among children...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Centers for Disease Control and Prevention
2013-04-01
|
Series: | Emerging Infectious Diseases |
Subjects: | |
Online Access: | https://wwwnc.cdc.gov/eid/article/19/4/12-1198_article |
id |
doaj-10602accd46a46148231fbb9312a9e58 |
---|---|
record_format |
Article |
spelling |
doaj-10602accd46a46148231fbb9312a9e582020-11-25T00:33:25ZengCenters for Disease Control and PreventionEmerging Infectious Diseases1080-60401080-60592013-04-0119458959710.3201/eid1904.121198Effect of 10-Valent Pneumococcal Vaccine on Pneumonia among Children, BrazilEliane Terezinha AfonsoRuth MinamisavaAna Luiza BierrenbachJuan Jose Cortez EscalanteAirlane Pereira AlencarCarla Magda DominguesOtaliba Libanio Morais-NetoCristiana Maria ToscanoAna Lucia AndradePneumonia is most problematic for children in developing countries. In 2010, Brazil introduced a 10-valent pneumococcal conjugate vaccine (PCV10) to its National Immunization Program. To assess the vaccine’s effectiveness for preventing pneumonia, we analyzed rates of hospitalization among children 2–24 months of age who had pneumonia from all causes from January 2005 through August 2011. We used data from the National Hospitalization Information System to conduct an interrupted time-series analysis for 5 cities in Brazil that had good data quality and high PCV10 vaccination coverage. Of the 197,975 hospitalizations analyzed, 30% were for pneumonia. Significant declines in hospitalizations for pneumonia were noted in Belo Horizonte (28.7%), Curitiba (23.3%), and Recife (27.4%) but not in São Paulo and Porto Alegre. However, in the latter 2 cities, vaccination coverage was less than that in the former 3. Overall, 1 year after introduction of PCV10, hospitalizations of children for pneumonia were reduced.https://wwwnc.cdc.gov/eid/article/19/4/12-1198_articlePneumoniapneumococcal vaccinesPCV10time-series analysisvaccinationhospitalization |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Eliane Terezinha Afonso Ruth Minamisava Ana Luiza Bierrenbach Juan Jose Cortez Escalante Airlane Pereira Alencar Carla Magda Domingues Otaliba Libanio Morais-Neto Cristiana Maria Toscano Ana Lucia Andrade |
spellingShingle |
Eliane Terezinha Afonso Ruth Minamisava Ana Luiza Bierrenbach Juan Jose Cortez Escalante Airlane Pereira Alencar Carla Magda Domingues Otaliba Libanio Morais-Neto Cristiana Maria Toscano Ana Lucia Andrade Effect of 10-Valent Pneumococcal Vaccine on Pneumonia among Children, Brazil Emerging Infectious Diseases Pneumonia pneumococcal vaccines PCV10 time-series analysis vaccination hospitalization |
author_facet |
Eliane Terezinha Afonso Ruth Minamisava Ana Luiza Bierrenbach Juan Jose Cortez Escalante Airlane Pereira Alencar Carla Magda Domingues Otaliba Libanio Morais-Neto Cristiana Maria Toscano Ana Lucia Andrade |
author_sort |
Eliane Terezinha Afonso |
title |
Effect of 10-Valent Pneumococcal Vaccine on Pneumonia among Children, Brazil |
title_short |
Effect of 10-Valent Pneumococcal Vaccine on Pneumonia among Children, Brazil |
title_full |
Effect of 10-Valent Pneumococcal Vaccine on Pneumonia among Children, Brazil |
title_fullStr |
Effect of 10-Valent Pneumococcal Vaccine on Pneumonia among Children, Brazil |
title_full_unstemmed |
Effect of 10-Valent Pneumococcal Vaccine on Pneumonia among Children, Brazil |
title_sort |
effect of 10-valent pneumococcal vaccine on pneumonia among children, brazil |
publisher |
Centers for Disease Control and Prevention |
series |
Emerging Infectious Diseases |
issn |
1080-6040 1080-6059 |
publishDate |
2013-04-01 |
description |
Pneumonia is most problematic for children in developing countries. In 2010, Brazil introduced a 10-valent pneumococcal conjugate vaccine (PCV10) to its National Immunization Program. To assess the vaccine’s effectiveness for preventing pneumonia, we analyzed rates of hospitalization among children 2–24 months of age who had pneumonia from all causes from January 2005 through August 2011. We used data from the National Hospitalization Information System to conduct an interrupted time-series analysis for 5 cities in Brazil that had good data quality and high PCV10 vaccination coverage. Of the 197,975 hospitalizations analyzed, 30% were for pneumonia. Significant declines in hospitalizations for pneumonia were noted in Belo Horizonte (28.7%), Curitiba (23.3%), and Recife (27.4%) but not in São Paulo and Porto Alegre. However, in the latter 2 cities, vaccination coverage was less than that in the former 3. Overall, 1 year after introduction of PCV10, hospitalizations of children for pneumonia were reduced. |
topic |
Pneumonia pneumococcal vaccines PCV10 time-series analysis vaccination hospitalization |
url |
https://wwwnc.cdc.gov/eid/article/19/4/12-1198_article |
work_keys_str_mv |
AT elianeterezinhaafonso effectof10valentpneumococcalvaccineonpneumoniaamongchildrenbrazil AT ruthminamisava effectof10valentpneumococcalvaccineonpneumoniaamongchildrenbrazil AT analuizabierrenbach effectof10valentpneumococcalvaccineonpneumoniaamongchildrenbrazil AT juanjosecortezescalante effectof10valentpneumococcalvaccineonpneumoniaamongchildrenbrazil AT airlanepereiraalencar effectof10valentpneumococcalvaccineonpneumoniaamongchildrenbrazil AT carlamagdadomingues effectof10valentpneumococcalvaccineonpneumoniaamongchildrenbrazil AT otalibalibaniomoraisneto effectof10valentpneumococcalvaccineonpneumoniaamongchildrenbrazil AT cristianamariatoscano effectof10valentpneumococcalvaccineonpneumoniaamongchildrenbrazil AT analuciaandrade effectof10valentpneumococcalvaccineonpneumoniaamongchildrenbrazil |
_version_ |
1725316974687289344 |